MedPath

Mesna

These highlights do not include all the information needed to use MESNA INJECTION safely and effectively. See full prescribing information for MESNA INJECTION. MESNA injection, for intravenous useInitial U.S. Approval: 1988

Approved
Approval ID

2a2a526f-636b-7920-4261-6c626f612a2a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 14, 2021

Manufacturers
FDA

Sagent Pharmaceuticals

DUNS: 796852890

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

mesna

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code25021-201
Application NumberANDA090913
Product Classification
M
Marketing Category
C73584
G
Generic Name
mesna
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 21, 2019
FDA Product Classification

INGREDIENTS (5)

mesnaActive
Quantity: 100 mg in 1 mL
Code: NR7O1405Q9
Classification: ACTIB
edetate disodiumInactive
Code: 7FLD91C86K
Classification: IACT
benzyl alcoholInactive
Code: LKG8494WBH
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mesna - FDA Drug Approval Details